Advertising

NASDAQ:CRDF

3.44
0.18 (4.97%) 1d
0
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »
DON'T BUY
Merely okay. Very speculative and not as far along as he'd like. They're developing five products.
medical services
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

Cardiff Oncology (CRDF-Q) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 1

Stockchase rating for Cardiff Oncology is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Cardiff Oncology (CRDF-Q) Frequently Asked Questions

What is Cardiff Oncology stock symbol?

Cardiff Oncology is a American stock, trading under the symbol CRDF-Q on the NASDAQ (CRDF). It is usually referred to as NASDAQ:CRDF or CRDF-Q

Is Cardiff Oncology a buy or a sell?

In the last year, 1 stock analyst published opinions about CRDF-Q. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Cardiff Oncology .

Is Cardiff Oncology a good investment or a top pick?

Cardiff Oncology was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Cardiff Oncology .

Why is Cardiff Oncology stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Cardiff Oncology worth watching?

In the last year, there was no coverage of Cardiff Oncology published on Stockchase.

What is Cardiff Oncology stock price?

On 2022-01-25, Cardiff Oncology (CRDF-Q) stock closed at a price of $3.44.